Related Experiment Video
Updated: May 8, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Presymptomatic Testing for Huntington's Disease in Mexico: 28 Years of Experience
Adriana Ochoa-Morales1, David José Dávila-Ortiz de Montellano1, Mireya Chávez-Oliveros2
1Genetics Department, National Institute of Neurology and Neurosurgery, Manuel Velasco Suárez, Mexico City, Mexico.
Introduction:
Huntington's disease (HD) is a genetic neurodegenerative disorder with dominant inheritance. Our center in Mexico City has offered presymptomatic testing (PT) since 1995.
Objective:
To describe the main clinical and demographic characteristics of at-risk HD individuals who applied to the PT program, the reasons for seeking it, and the molecular results.
Methods:
A cross-sectional study was conducted with sociodemographic and clinical data of all PT applicants from 1995-2023. Reasons for seeking PT were assessed using a modified questionnaire. In addition, anxiety, and depressive symptoms before and after PT were evaluated with Beck's instruments; cognitive impairment (CI) was assessed with the Mini-Mental State Examination (MMSE) and molecular results.
Results:
214 people applied for PT (2.1% of the at-risk population identified in our center); 63% were women (mean age of 37.11 years). 204 (95.3%) were accepted and 190 received results. 70% indicated that the main reason for applying for PT was to inform their offspring about the risk of inheriting HD. Significant differences were observed in the reasons for seeking PT by age group. Although some subjects received treatment, Beck's instrument scores did not indicate special attention or pharmacological treatment. The MMSE showed probable CI in 20 subjects. Of those who received results, 37% were carriers of a full penetrance allele.
Conclusion:
Our center has the only formal PT program for HD in Mexico. The reasons for seeking PT are varied and age-related. Although PT is offered to all subjects at risk for HD, uptake remains low.
More Related Videos
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Holter Monitor: 24-Hour Monitoring
Mitral Stenosis II: Clinical features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Huntington Disease l: Introduction